FDA Panel Votes to Legalize BPC-157: Why Hims Stock Could Surge on Peptide Gold Rush
An FDA advisory panel voted 11-3 to place BPC-157 on the compounding list, signaling a major regulatory shift for the $1.2 billion peptide market. Hims...
Enter your email to receive a secure code. No password needed.
请选择您喜欢的登录方式
